In this context, it is interesting to observe that the BASP1-interaction partner CaM induces ERα dimerization, and that disruption of the ERα/CaM interaction could represent a potential therapeutic strategy for targeting ERα-positive breast cancers (31). The gene discussed is BASP1; the disease is breast carcinoma.